In: Interactive CardioVascular and Thoracic Surgery, 2017, vol. 24, no. 6, p. 967-968
|
In: Lung, 2015, vol. 193, no. 1, p. 113-120
|
In: Psychopharmacology, 2015, vol. 232, no. 16, p. 2981-2994
|
In: Archives of Gynecology and Obstetrics, 2015, vol. 291, no. 6, p. 1213-1220
|
In: International Journal of Legal Medicine, 2015, vol. 129, no. 5, p. 1067-1077
|
In: European Radiology, 2015, vol. 25, no. 6, p. 1684-1691
|
In: Open forum infectious diseases, 2015, vol. 2, no. 3, p. ofv084
Background: Human noroviruses are the leading cause of acute viral gastroenteritis, justifying vaccine development despite a limited understanding of strain immunity. After genogroup I (GI).1 norovirus infection and immunization, blockade antibody titers to multiple virus-like particles (VLPs) increase, suggesting that GI cross-protection may occur. Methods: Immunoglobulin (Ig)A was purified...
|
In: International Journal of Legal Medicine, 2014, vol. 128, no. 1, p. 127-137
|
In: European Journal of Nuclear Medicine and Molecular Imaging, 2014, vol. 41, p. 91-103
|
In: Internal and Emergency Medicine, 2014, vol. 9, no. 3, p. 335-339
|